1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid
97%
- Product Code: 208643
CAS:
503614-92-4
| Molecular Weight: | 460.48 g./mol | Molecular Formula: | C₂₅H₂₄N₄O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22376657 | |
| Melting Point: | Boiling Point: | 807.2±65.0°C at 760 mmHg | |
| Density: | Storage Condition: | 2-8°C, dry seal |
Product Description:
Used in pharmaceutical research as a potent and selective inhibitor of phosphodiesterase 10A (PDE10A), this compound is investigated for its potential in treating central nervous system disorders, particularly schizophrenia and other psychiatric conditions involving dysregulation of dopamine signaling. By inhibiting PDE10A, it increases intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in specific brain regions, modulating neuronal activity in the striatum. It serves as a tool compound in preclinical studies to explore the role of PDE10A in cognitive function, motivation, and psychomotor behavior. Its structure supports high blood-brain barrier penetration, making it suitable for in vivo studies targeting brain pathways.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | ฿1,070.00 |
+
-
|
| 250mg | 10-20 days | ฿2,050.00 |
+
-
|
| 1g | 10-20 days | ฿6,650.00 |
+
-
|
| 5g | 10-20 days | ฿31,990.00 |
+
-
|
1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid
Used in pharmaceutical research as a potent and selective inhibitor of phosphodiesterase 10A (PDE10A), this compound is investigated for its potential in treating central nervous system disorders, particularly schizophrenia and other psychiatric conditions involving dysregulation of dopamine signaling. By inhibiting PDE10A, it increases intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in specific brain regions, modulating neuronal activity in the striatum. It serves as a tool compound in preclinical studies to explore the role of PDE10A in cognitive function, motivation, and psychomotor behavior. Its structure supports high blood-brain barrier penetration, making it suitable for in vivo studies targeting brain pathways.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :